Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 48Unknown 18Recruiting 9Terminated 6Active not recruiting 5Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

Paclitaxel 3Surgical Procedures, Operative 2Radiotherapy 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Doxorubicin 2Cyclophosphamide 2titanium silicide 1sargramostim 1exemestane 1eribulin 1cemiplimab 1Vincristine 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Specimen Handling 1S 1 (combination) 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Prednisone 1Prednisolone 1Passive Cutaneous Anaphylaxis 1Neoadjuvant Therapy 1Morphine 1Methylprednisolone 1Methotrexate 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Melphalan × Clear all
NCT00892346 2016-05-10

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

Shanghai Jiao Tong University School of Medicine

Phase 3 Suspended
80 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡